CIMAvax-EGF: A New Therapeutic Vaccine for Advanced Non-Small Cell Lung Cancer Patients

Lung cancer is the common fatal illness with the highest incidence and mortality globally. Epidermal growth factor receptor overexpression by tumor cells is associated with uncontrolled proliferation, angiogenesis, anti-apoptotic signals, metastization, and invasiveness. CIMAvax-EGF vaccine consists...

Descripción completa

Detalles Bibliográficos
Autores principales: Saavedra, Danay, Crombet, Tania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346887/
https://www.ncbi.nlm.nih.gov/pubmed/28348561
http://dx.doi.org/10.3389/fimmu.2017.00269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346887/
https://www.ncbi.nlm.nih.gov/pubmed/28348561
http://dx.doi.org/10.3389/fimmu.2017.00269

Ejemplares similares